Cargando…

Synthesis, Structure and Antitumour Properties of a New 1,2-Propylenediaminetetraacetate-Ruthenium(III) Compound

A novel complex formed by ruthenium (III) and the sequestering ligand 1,2-propylenediaminetetraacetic acid (PDTA) has been synthetized and characterized. The structure of the monomeric compound, studied by X-ray diffraction , shows an almost symmetric octahedral geometry around the metal ion, with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilaplana, R., Romero, M. A., Quirós, M., Salas, J. M., González-Vílchez, F.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364974/ https://www.ncbi.nlm.nih.gov/pubmed/18472768 http://dx.doi.org/10.1155/MBD.1995.211

Ejemplares similares

Isolation, Characterization and Antitumour Propirties of the 1,2-Popylenediaminetetraacetate trans-Diaqua-Copper (II)
por: Kamah, S., et al.
Publicado: (2000)

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins
por: Messori, L., et al.
Publicado: (2000)

Molecular insights on the biosynthesis of antitumour compounds by actinomycetes
por: Olano, Carlos, et al.
Publicado: (2011)

Redesigning Nature: Ruthenium Flavonoid Complexes with Antitumour, Antimicrobial and Cardioprotective Activities
por: Santos, Nádia E., et al.
Publicado: (2021)

Synthesis, Structure, Properties And Biological Behaviour Of The Complex [Ru(IV) (H(2)L) Cl(2)].2H(2)O (H(4)L= 1,2-Cyclohexanediamminetetraacetic Acid)
por: Vilaplana, Rosario A., et al.
Publicado: (2004)

Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line
por: Kratz, F., et al.
Publicado: (1996)

Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds
por: Starosta, Radoslaw, et al.
Publicado: (2023)

Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
por: Kljun, Jakob, et al.
Publicado: (2010)

Antitumour Activity of a pt(III) Derivative of 2-Mercaptopyrimidine
por: Cervantes, G., et al.
Publicado: (1997)

Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin
por: Kratz, F., et al.
Publicado: (1994)

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
por: Morbidelli, L, et al.
Publicado: (2003)

Site-specific antitumour effects of 2 pyrimidinone compounds in rats.
por: Eggermont, A. M., et al.
Publicado: (1986)

Synthesis, Characterisation and Antitumour Activity of Some Quercetin Analogues
por: Gadhwal, M. K., et al.
Publicado: (2013)

Antitumoural Sulphur and Selenium Heteroaryl Compounds: Thermal Characterization and Stability Evaluation
por: Alcolea, Verónica, et al.
Publicado: (2017)

Platinum(II)-Acyclovir Complexes: Synthesis, Antiviral and Antitumour Activity
por: Coluccia, M., et al.
Publicado: (1995)

Water-Soluble Ruthenium(III)-Dimethyl Sulfoxide Complexes: Chemical Behaviour and Pharmaceutical Properties
por: Mestroni, G., et al.
Publicado: (1994)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Computational DFT data related to the redox behaviour of tris(β-diketonato)ruthenium(III) compounds
por: Conradie, Jeanet
Publicado: (2020)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
por: Stammer, Rahel Mascha, et al.
Publicado: (2017)

Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis, Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent
por: Ejidike, Ikechukwu P., et al.
Publicado: (2016)

Enantiomeric Complexes Based on Ruthenium(III) and 2,2′-Biimidazole: X-ray Structure and Magnetic Properties
por: Orts-Arroyo, Marta, et al.
Publicado: (2023)

Antitumour activity of adenovirus-12 structural proteins against Moloney sarcoma tumours in mice.
por: Abid, S. H., et al.
Publicado: (1976)

Spherical Silica Modified with Magnesium and Ruthenium—Synthesis, Characterization and Catalytic Properties
por: Grzelak, Kalina, et al.
Publicado: (2021)

Room-Temperature Synthesis of Thioether-Stabilized Ruthenium Nanocubes and Their Optical Properties
por: Adams, Clara P., et al.
Publicado: (2023)

Synthesis, Characterization and Antitumour Activity of Di-n-Butyltin Salicyloxamate
por: Gielen, Marcel, et al.
Publicado: (1998)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
por: Hou, Xi-Xi, et al.
Publicado: (2023)

Crystal structures of five compounds in the aluminium–ruthenium–silicon system
por: Kitahara, Koichi, et al.
Publicado: (2023)

Toxicity Profiles In Vivo in Mice and Antitumour Activity in Tumour-Bearing Mice of Di- and Triorganotin Compounds
por: Gielen, M., et al.
Publicado: (1998)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

Synthesis, Characterization and In vitro Antitumour Activity of Novel Organotin Derivatives of 1,2- and 1,7-Dicarba-Closo-dodecaboranes
por: Gielen, Marcel, et al.
Publicado: (1995)

Antimetastatic activity of novel ruthenium (III) pyridine complexes
por: Gu, Liwei, et al.
Publicado: (2016)

Targeted antitumour therapy – future perspectives
por: Ranson, M, et al.
Publicado: (2005)

Synthesis, Characterization, In Vitro Cytotoxicity, and Apoptosis-Inducing Properties of Ruthenium(II) Complexes
por: Xu, Li, et al.
Publicado: (2014)

Antiproliferative and Antitumour Effect of Nongenotoxic Silver Nanoparticles on Melanoma Models
por: Valenzuela-Salas, Lucía M., et al.
Publicado: (2019)

Synthesis, Characterization and High In Vitro Antitumour Activity of Novel Triphenyltin Carboxylates
por: Gielen, Marcel, et al.
Publicado: (1994)

Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds
por: Kljun, Jakob, et al.
Publicado: (2023)

Antitumour Organometallics. III. In Vivo Activity of Diphenylantimony(III) and Diorganotin(IV) Dithiophosphorus Derivatives Against P388 Leukemia
por: Keppler, Bernhard K., et al.
Publicado: (1994)

Effect of nitrogen compounds on transport of ruthenium through the RCS
por: Kajan, Ivan, et al.
Publicado: (2017)

Fighting Multidrug Resistance with Ruthenium–Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition
por: Teixeira, Ricardo G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l1rdk5aif1neiqrv5ja0jqb2af